Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aladdin M Bhuiyan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|November 17, 2021
Engineering T cell memory for antitumor immunityAladdin M Bhuiyan, Michael Dougan
Nature|March 29, 2023
Ornithine aminotransferase supports polyamine synthesis in pancreatic cancerMin-Sik Lee, Courtney Dennis, Insia Naqvi, et al.
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Nature|October 22, 2020
Immune receptor inhibition through enforced phosphatase recruitmentRicardo A Fernandes, Leon Su, Yoko Nishiga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Science Translational Medicine|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|November 17, 2021
Engineering T cell memory for antitumor immunityAladdin M Bhuiyan, Michael Dougan
Nature|March 29, 2023
Ornithine aminotransferase supports polyamine synthesis in pancreatic cancerMin-Sik Lee, Courtney Dennis, Insia Naqvi, et al.
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Nature|October 22, 2020
Immune receptor inhibition through enforced phosphatase recruitmentRicardo A Fernandes, Leon Su, Yoko Nishiga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2023
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent ImmunityKatherine S Ventre, Kevin Roehle, Elisa Bello, et al.
Science Translational Medicine|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.
Pageof 1